Lim E, et al. In hospital clinical efficacy, safety and oncologic outcomes from VIOLET: a UK multi-centre RCT of VATS versus open lobectomy for lung cancer. Abstract PL02.06. WCLC 2019, 7-10 september, Barcelona, Spanje.
Pembrolizumab plus mFOLFOX7 of FOLFIRI bij MSS/MMR-proficiënt mCRC
okt 2024 | Immuuntherapie, Maag-darm-leveroncologie